Cochrane2019Ia
Cochrane Review: Strength training and aerobic exercise training for muscle disease
Zusammenfassung
# Strength training and aerobic exercise training for muscle disease.
## BACKGROUND
Strength training or aerobic exercise programmes, or both, might optimise muscle and cardiorespiratory function and prevent additional disuse atrophy and deconditioning in people with a muscle disease. This is an update of a review first published in 2004 and last updated in 2013. We undertook an update to incorporate new evidence in this active area of research.
## OBJECTIVES
To assess the effects (benefits
Kerninformationen
Randomised controlled trials (RCTs), quasi-RCTs or cross-over RCTs comparing strength or aerobic exercise training, or both lasting at least six weeks, to no training in people with a well-described muscle disease diagnosis.
## DATA COLLECTION AND ANALYSIS
We used standard methodological procedur...
intention-to-treat analysis. Strength training compared to no training (3 trials) For participants with FSHD (35 participants), there was low-certainty evidence of little or no effect on dynamic strength of elbow flexors (MD 1.2 kgF, 95% CI -0.2 to 2.6), on isometric strength of elbow flexors (MD 0...
tric wrist flexor force (MD 7.0 N, 95% CI -3.4 to 17.4). Aerobic exercise training compared to no training (5 trials) For participants with DMD there was very low-certainty evidence regarding the number of leg revolutions (MD 14.0, 95% CI -89.0 to 117.0; 23 participants) or arm revolutions (MD 34.8,...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2019
Cochrane Review: Physical exercise training for type 3 spinal muscular atrophy
Cochrane2021
Cochrane Review: Interventions for promoting physical activity in people with neuromuscular disease
Cochrane2021
Cochrane Review: Exercise for cancer cachexia in adults
Cochrane2019
Cochrane Review: Respiratory muscle training in children and adults with neuromuscular disease
Cochrane2019